Group 1 - Government influence over educational institutions has become a significant point of social and political debate [1] - Adtalem Global Education Inc. (NYSE: ATGE) is actively engaging in this discourse [1] Group 2 - The article reflects the author's personal experiences and insights related to teaching and consulting in the education sector [1]

Key Takeaways NGS, ASC, ATGE, and RGCO show strong net margins and upward EPS revisions for fiscal 2025. All four stocks have Zacks Ranks of 1 or 2 and VGM Scores of A or B, indicating solid upside potential. Each company has an impressive track record of beating earnings estimates.The primary purpose of a business is to generate profits that can be reinvested in expansion or utilized for rewarding shareholders. The net profit margin is an effective tool to measure the profits reaped by a business.A highe ...

Company Performance - Adtalem Global Education (ATGE) has gained approximately 41.4% year-to-date, significantly outperforming the average gain of 11.2% in the Consumer Discretionary sector [4] - The Zacks Consensus Estimate for ATGE's full-year earnings has increased by 5.1% in the past quarter, indicating improved analyst sentiment and earnings outlook [4] - Adtalem Global Education holds a Zacks Rank of 2 (Buy), suggesting a favorable investment outlook [3] Industry Context - Adtalem Global Education is part of the Schools industry, which ranks 10 in the Zacks Industry Rank, with an average gain of 10.4% this year [6] - The Consumer Discretionary group, which includes 255 companies, currently ranks 9 within the Zacks Sector Rank [2] - Fox (FOXA), another stock in the Consumer Discretionary sector, has returned 16.9% year-to-date and also holds a Zacks Rank of 2 (Buy) [5]

Company Performance - Adtalem Global Education (ATGE) has returned approximately 32% year-to-date, significantly outperforming the average gain of 5.8% in the Consumer Discretionary sector [4] - The Zacks Consensus Estimate for ATGE's full-year earnings has increased by 5.1% over the past three months, indicating improved analyst sentiment and earnings outlook [4] - Adtalem Global Education is ranked 2 (Buy) in the Zacks Rank, suggesting strong potential for future performance [3] Industry Comparison - Adtalem Global Education is part of the Schools industry, which ranks 17 in the Zacks Industry Rank, with an average gain of 6% this year, indicating that ATGE is performing better than its industry peers [6] - In contrast, Fox (FOXA), another Consumer Discretionary stock, has returned 10.8% year-to-date and is part of the Broadcast Radio and Television industry, which ranks 78 and has gained 25.5% this year [5][6] - The Consumer Discretionary sector as a whole is ranked 12 among 16 different sector groups in the Zacks Sector Rank [2]

Adtalem Global Education (ATGE) 2025 Conference June 04, 2025 03:45 PM ET Speaker0 All right. We're gonna get started. Good afternoon. My name is Steven Pollock, the Baird research analyst covering post secondary education here at Baird. Our next presenting company is Adtalem Global Education. They operate five healthcare focused institutions in The U. S. With more than 80,000 students currently enrolled. Here from the company, we have CEO, Steve Beard. We also have in the audience CFO, Bob Phelan and Head ...

Core Viewpoint - Investors are evaluating the value opportunities presented by Adtalem Global Education (ATGE) and Universal Technical Institute (UTI) in the current market [1] Group 1: Zacks Rank and Value Scores - Both ATGE and UTI currently hold a Zacks Rank of 2 (Buy), indicating positive earnings estimate revisions and improving earnings outlooks [3] - The Zacks Rank is a strategy that targets companies with favorable earnings estimate trends, while the Style Scores assess companies based on specific traits [2] Group 2: Valuation Metrics - ATGE has a forward P/E ratio of 19.90, while UTI has a higher forward P/E of 33.82 [5] - ATGE's PEG ratio is 1.33, which is more favorable compared to UTI's PEG ratio of 2.25, indicating better expected EPS growth relative to its valuation [5] - ATGE's P/B ratio stands at 3.37, significantly lower than UTI's P/B of 6.62, suggesting ATGE is more undervalued based on its book value [6] Group 3: Overall Value Assessment - Based on various valuation metrics, ATGE is assigned a Value grade of B, while UTI receives a Value grade of C, indicating that ATGE is currently the superior value option [6]

Core Viewpoint - Adtalem Global Education Inc. (ATGE) has demonstrated strong stock performance with a year-to-date increase of 42.6%, significantly outperforming the Zacks Schools industry and the broader market indices [1][2]. Financial Performance - The Zacks Consensus Estimate for fiscal 2025 earnings per share has increased to $6.42 from $6.20 over the past 60 days, indicating a growth of 28.1% compared to the previous year [3]. - For fiscal 2025, Adtalem expects revenues to be between $1,760 million and $1,775 million, an increase from the prior estimate of $1,730 million to $1,760 million. Adjusted EPS is projected to be in the range of $6.40 to $6.60, up from $6.10 to $6.30 [10]. Growth Drivers - The company is experiencing solid enrollment growth, with total student enrollment rising 9.8% year over year to 94,223 students, marking the 12th consecutive quarter of growth [8]. - Adtalem's Growth with Purpose strategy emphasizes sustainable progress and strategic execution, which is expected to enhance performance and long-term value creation [9]. - The company has partnered with Hippocratic AI, Inc. to develop a curriculum for training clinicians in AI healthcare applications, showcasing its focus on innovation and collaboration [7]. Market Position and Demand - Adtalem is addressing the nationwide shortage of healthcare professionals by aligning its programs with evolving workforce demands, particularly in nursing and healthcare education [11]. - The Practice Ready Specialty Focused program has enrolled over 4,000 students, with 900 completing specialty rotations, indicating a strong commitment to reshaping nursing education [12]. Challenges - The company faces margin pressure in the Medical and Veterinary segment and increased expenses, with the cost of educational services rising 10.9% year over year to $572.5 million [2][13].

Company Overview - Adtalem Global Education Inc. is a leading healthcare education provider and workforce solutions innovator, offering a wide array of programs across medical and healthcare services [12]. Zacks Rank and Style Scores - Adtalem has a Zacks Rank of 3 (Hold) and a VGM Score of A, indicating a solid position in the market [12]. - The company has a Momentum Style Score of A, with shares increasing by 26% over the past four weeks [13]. - One analyst has revised their earnings estimate upwards for fiscal 2025, with the Zacks Consensus Estimate increasing by $0.12 to $6.32 per share [13]. - Adtalem boasts an average earnings surprise of 18.4%, highlighting its potential for positive performance [13]. Investment Considerations - With a solid Zacks Rank and top-tier Momentum and VGM Style Scores, Adtalem should be on investors' short list for potential investment opportunities [13].

Core Insights - Adtalem Global Education Inc. (ATGE) reported strong third-quarter fiscal 2025 results, with adjusted earnings and revenues exceeding expectations and showing year-over-year growth [1][3] - The company's performance was driven by increased enrollment and higher tuition rates across all reportable segments, supported by strategic investments to enhance student experience [1][2] Earnings & Revenue Discussion - Adjusted earnings per share (EPS) reached $1.92, surpassing the Zacks Consensus Estimate of $1.63 by 17.8%, and increased from $1.50 in the prior year [3] - Revenues totaled $466.1 million, exceeding the consensus mark of $444 million by 4.9% and growing 12.9% year over year [3] - Total student enrollment rose 9.8% year over year to 94,223 students, compared to a predicted enrollment of 88,056 [3] Operating Performance - Adjusted operating income increased 17.4% year over year to $105.4 million, with an adjusted operating margin expanding 80 basis points to 22.6% [4] - Adjusted EBITDA was $127.8 million, up 19.3% from the prior year, with an adjusted EBITDA margin expanding 150 basis points to 27.4% [4] Segment Performance - Chamberlain segment revenues increased 13.1% year over year to $192.6 million, with total student enrollment rising 6.8% to 40,564 students [5] - Walden segment generated revenues of $178.4 million, up 18.5% year over year, with total student enrollment increasing 13.5% to 48,526 students [7] - Medical and Veterinary segment revenues increased 3.6% to $95 million, with total student enrollment slightly up by 1.2% to 5,133 students [8] Liquidity & Cash Flow - As of March 31, 2025, Adtalem had cash and cash equivalents of $219 million, with long-term debt reduced to $552.2 million from $648.7 million at the end of fiscal 2024 [10] - For the first nine months of fiscal 2025, cash provided by operating activities totaled $273.8 million, up from $227.1 million in the prior year [11] Fiscal 2025 Guidance - Adtalem raised its fiscal 2025 revenue guidance to a range of $1,760-$1,775 million, up from the previous estimate of $1,730-$1,760 million, and adjusted earnings guidance to $6.40-$6.60 per share from $6.10-$6.30 [12]

Q3 2025 Performance Highlights - Adtalem's revenue reached $466.1 million, a 12.9% increase compared to the prior year[16] - Adjusted EBITDA margin was 27.4%, a 150 bps increase compared to the prior year[17] - Adjusted EPS was $1.92, a 28.0% increase compared to the prior year[17] - Total enrollment grew by 9.8% year-over-year[15] Segment Performance - Chamberlain's revenue increased by 13.1% to $192.6 million, with a 6.8% increase in total enrollment[30] - Walden's revenue increased by 18.5% to $178.4 million, with a 13.5% increase in total enrollment[35] - Medical & Veterinary revenue increased by 3.6% to $95.0 million, with a 1.2% increase in total enrollment[40] Cash Flow and Capital Allocation - Trailing twelve months free cash flow was $287 million[21] - The company repaid $100 million of outstanding Term Loan B balance on January 17, 2025[21] - A new $150 million share repurchase authorization was approved through May 2028[21] FY 2025 Guidance - The company raised its revenue outlook to $1.760 billion - $1.775 billion[46] - The company raised its Adjusted EPS outlook to $6.40 - $6.60[46]